# Oral Propionate to Treat and Prevent Diabetes

> **NCT01692002** · NA · TERMINATED · sponsor: **Imperial College London** · enrollment: 6 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** Sodium propionate
- **DIETARY_SUPPLEMENT:** Sodium Chloride
- **PROCEDURE:** Oral glucose tolerance test
- **PROCEDURE:** Intravenous glucose tolerance test.

## Key facts

- **NCT ID:** NCT01692002
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** The person who was running the study never completed it, as the study never reached the target recruitment levels.
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01692002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01692002, "Oral Propionate to Treat and Prevent Diabetes". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01692002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*